先聲藥業(02096.HK)完成根據受限制股份單位計劃發行1346.9萬股

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

先聲藥業(02096.HK)完成根據受限制股份單位計劃發行1346.9萬股

格隆匯 11-04 21:16

格隆匯11月4日丨先聲藥業(02096.HK)公吿，完成根據2021年受限制股份單位計劃發行新股份。董事會欣然宣佈聯交所上市委員會已批准新股份上市及買賣。發行新股份的所有先決條件均已達成且公司已於2022年11月4日向Tricor受託人發行合共1346.9萬股新股份，由Tricor受託人以信託方式代承授人持有。新股份佔經發行及配發新股份擴大的已發行股份總數約0.506%，且新股份根據一般授權發行。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

先聲藥業(02096.HK)完成根據受限制股份單位計劃發行1346.9萬股

Services

About Us

Agreement Statement